Navigation Links
Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
Date:8/7/2012

SAN DIEGO, Aug. 7, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012. For the three months ended June 30, 2012, Orexigen reported a net loss of $16.7 million, or $0.25 per share, as compared to a net loss of $7.6 million, or $0.16 per share, for the second quarter of 2011. As of June 30, 2012, Orexigen had $67.4 million in cash and cash equivalents and an additional $58.8 million in marketable securities, for a total of $126.2 million.

Total operating expenses for the second quarter of 2012 were $17.6 million compared to $8.3 million for the second quarter of 2011. This overall increase in operating expenses reflects an increase in research and development expenses associated with the conduct of the Light Study, the Contrave® cardiovascular outcomes trial.

"We are pleased to see that the coordinated effort of our team and our partners is resulting in terrific progress for the Light Study, which continues to rapidly enroll the targeted patient population," said Michael Narachi, president and CEO of Orexigen. "We remain focused on doing everything we can to pull forward the time to resubmission of the Contrave NDA."

"We are encouraged that the FDA has recently approved two weight loss drugs, and we congratulate our colleagues at Arena and Vivus on their recent success," Narachi continued. "With a pipeline of two late stage obesity therapeutics, this is clearly also good news for Orexigen."

Product candidate update:

  • Contrave® (32 mg naltrexone sustained-release (SR)/360 mg bupropion SR) for the treatment of obesity: In the second quarter, Orexigen initiated the Light Study which is designed to be conducted at approximately 300 sites in the United States. The primary ob
    '/>"/>

  • SOURCE Orexigen Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
    2. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
    3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
    4. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
    5. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
    6. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
    7. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
    8. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
    9. Silence Therapeutics - Admission of Shares and Board Update
    10. OrPro Therapeutics Receives NIH Grant Award to Advance Development of Recombinant Thioredoxin for Treatment of Cystic Fibrosis
    11. Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2014)... By now, if you haven,t heard about the ... planet. The awareness campaign has brought this devastating disease to ... over $88.5 Million (and counting) for ALS. Every day, more ... starting to as well. One such company, Acorn ... who actually works with ALS sufferers and helps to provide ...
    (Date:8/27/2014)... CHICAGO , Aug. 27, 2014  Hill-Rom Holdings, ... listen to a management presentation at the Morgan Stanley ... p.m. EDT. You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at ... be available one hour after conclusion of the live ...
    (Date:8/27/2014)... 27, 2014 North American lighting leader OSRAM ... Award for the new OSRAM ITOS ® PHASER ® ... module for microscopy, endoscopy and surgical head lamps that delivers ... efficacy and lamp life. "We,re honored to be ... most innovative new technologies of the past year," said ...
    Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
    (Date:8/27/2014)... 2014 According to a new market ... Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
    (Date:8/27/2014)... The National League for Nursing is pleased ... FAAN, became the inaugural director of the NLN/Chamberlain ... Science of Nursing Education , effective August 11. The ... Home for Transformative Excellence, established with the League’s historic ... , Under Dr. Dennis’s leadership, the NLN/Chamberlain Center will ...
    (Date:8/27/2014)... Delta, a reliable supplier of high ... Cat D7R Dozers to its used bulldozer ... announced that all these items are offered with deep ... expand Delta’s market share in the coming September. ... special offer; he has much confidence in the discounted ...
    (Date:8/27/2014)... FL (PRWEB) August 27, 2014 Millennium ... now a sponsor for Florida Mental Health Counselors Association ... benefits the new sponsorship is sure to provide. , ... professional needs of Florida’s licensed mental health counselors. The ... the American Counseling Association (ACA) and since then, it ...
    (Date:8/27/2014)... NY (PRWEB) August 27, 2014 The ... Team ) is holding free events about “ Sexuality ... speaker Liz Treston. These straightforward and entertaining discussions are ... at Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) and ... Central Avenue, Bethpage, NY). , The New York ...
    Breaking Medicine News(10 mins):Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Millennium Treatment Group Sponsors Florida Mental Health Counselors Association 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2
    ... Not Meeting Daily Physical,Activity Recommendations, INDIANAPOLIS, May ... homes are unlikely to be meeting physical activity,recommendations ... today,at the 55th Annual Meeting of the American ... family child care homes, as the second,largest child ...
    ... to Fitness, INDIANAPOLIS, May 30 If walking seems ... a stroll is,an easy way to lower pressure and for ... presented findings today at the,55th Annual Meeting of the American ... obese patients was designed to determine if,brisk walking alone was ...
    ... To Be Completed Within Automatic Form 10-K Extension ... ... May 30 KV Pharmaceutical Company,(NYSE: KVa/KVb), a fully integrated specialty ... prescription pharmaceuticals,announced today that it expects to complete and file its ...
    ... deployed in regions of the world where tuberculosis (TB) ... military now faces a growing medical problem. But it ... the problem lies with the growing number of pseudoepidemics, ... result of universal testing with a notoriously inaccurate tuberculin ...
    ... 30 The new University of,Detroit Mercy School of ... Saturday, May 31 from 9 a.m. to 1 p.m. ... offering free dental screenings for community,members, as well as ... held in celebration of the School of Dentistry,s 75th,Anniversary., ...
    ... MD, RDMS, of Christiana Care Health System, Wilmington, DE, ... with immediate access to patient medical records during a ... radiofrequency devices that electronically contain a persons medical records ... reduce medical charges, two often incompatible goals. , ...
    Cached Medicine News:Health News:Preschoolers in Family Child Care Homes Need More Activity 2Health News:Brisk Walking Lowers Blood Pressure, Increases Fitness in Obese 2Health News:KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings 2Health News:KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings 3Health News:US soldiers in high-tuberculosis areas face new epidemic: false positives 2Health News:UDM School of Dentistry to Host Community Open House 2
    ... Rapid 5 minutes immunoassay, based on ... a monoclonal antibody, for the qualitative ... human stool. The Premier Platinum HpSA, ... after extensive evaluation, was accepted as ...
    Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
    The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
    ... PRISM 310 Genetic Analyzer is an automated ... range of sequencing and fragment analysis applications. ... forensic labs who incorporate genetic analysis into ... the ideal alternative to gel-based DNA analysis ...
    Medicine Products: